chr3-187199594-G-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000312295.5(RTP1):āc.316G>Cā(p.Val106Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,605,090 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar.
Frequency
Consequence
ENST00000312295.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTP1 | NM_153708.3 | c.316G>C | p.Val106Leu | missense_variant | 2/2 | ENST00000312295.5 | NP_714919.2 | |
LOC101929106 | NR_110052.1 | n.1191C>G | non_coding_transcript_exon_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTP1 | ENST00000312295.5 | c.316G>C | p.Val106Leu | missense_variant | 2/2 | 1 | NM_153708.3 | ENSP00000311712.4 | ||
ENSG00000198491 | ENST00000356133.3 | n.1191C>G | non_coding_transcript_exon_variant | 3/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000301 AC: 75AN: 249342Hom.: 1 AF XY: 0.000215 AC XY: 29AN XY: 134668
GnomAD4 exome AF: 0.000156 AC: 227AN: 1452932Hom.: 2 Cov.: 30 AF XY: 0.000146 AC XY: 105AN XY: 720926
GnomAD4 genome AF: 0.000118 AC: 18AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74310
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at